glofitamab,Obinutuzumab 
roche
['glofitamab']
peter mac s a/prof is at #asco22 in chicago this morning discussing latest data on glofitamab, the investigational drug offering new hope for patients with hard to treat blood cancers. click to read. 
Peter Mac is an integrated cancer research, treatment and education centre. A place where normal days are extraordinary – as are the people we care for.